v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Revenue:        
Total revenue $ 9,238 $ 11,489 $ 26,193 $ 21,378
Operating expenses:        
Research and development 26,412 41,575 69,487 79,616
General and administrative 8,900 8,679 27,646 17,337
Total operating expenses 35,312 50,254 97,133 96,953
Loss from operations (26,074) (38,765) (70,940) (75,575)
Other income (expense)        
Interest income 268 542 622 836
Interest expense (2,705) (2,744) (5,460) (5,490)
Remeasurement of warrant liability 1,602 0 1,602 0
Remeasurement of derivative liability 4,113 0 4,113 0
Gain on debt extinguishment 43,846 0 43,846 0
Other income (loss), net (4,150) 2,694 (3,547) 5,318
Total other income, net 42,974 492 41,176 664
Net income (loss) 16,900 (38,273) (29,764) (74,911)
Other comprehensive income (loss):        
Foreign currency translation 291 (4,195) 1,483 (6,098)
Unrealized loss on marketable securities (1) (69) (68) (179)
Other comprehensive income (loss) 290 (4,264) 1,415 (6,277)
Comprehensive income (loss) $ 17,190 $ (42,537) $ (28,349) $ (81,188)
Net income (loss) per share, basic (in dollars per share) $ 0.05 $ (0.17) $ (0.11) $ (0.33)
Net income (loss) per share, diluted (in dollars per share) $ (0.08) $ (0.17) $ (0.24) $ (0.33)
Weighted average common shares outstanding, basic (in shares) 320,014,255 227,275,466 277,313,038 227,048,022
Weighted average common shares outstanding, diluted (in shares) 328,776,495 227,275,466 287,855,108 227,048,022
Revenue from contracts with collaborators        
Revenue:        
Total revenue $ 9,238 $ 11,489 $ 26,193 $ 21,378